Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction
Domingo A. Pascual‐Figal(Spanish National Centre for Cardiovascular Research), José J. Fuster(Spanish National Centre for Cardiovascular Research), Jorge de la Barrera(Spanish National Centre for Cardiovascular Research), Ana Dopazo(Spanish National Centre for Cardiovascular Research), Enrique Vázquez(Spanish National Centre for Cardiovascular Research), Ana Quintas(Spanish National Centre for Cardiovascular Research), Fátima Sánchez‐Cabo(Spanish National Centre for Cardiovascular Research), M. Lopez(Spanish National Centre for Cardiovascular Research), Miriam Díez-Díez(Spanish National Centre for Cardiovascular Research), Álvaro Hernández Vicente(Universidad de Murcia), María A. Zuriaga(Spanish National Centre for Cardiovascular Research), David José Vázquez Andrés(Hospital Universitario Virgen de la Arrixaca), Antoni Bayés‐Genís(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol)
Cited by 218
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
|Science|2017|1.5k
Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations
|European Journal of Heart Failure|2019|786
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
|Journal of the American College of Cardiology|2018|673
Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease
|Circulation Research|2016|662